UNICREDIT BANK/CALL/IDEXX LABORATORIES/500/0.01/15.01.25 Stock

Warrant

DE000HD4RVY9

Real-time BOERSE MUENCHEN 11:40:24 2024-06-27 EDT
0.43 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/IDEXX LABORATORIES/500/0.01/15.01.25
Current month-14.00%
1 month-33.85%
Date Price Change
24-06-27 0.43 0.00%
24-06-26 0.43 -2.27%
24-06-25 0.44 -4.35%
24-06-24 0.46 0.00%
24-06-21 0.46 -4.17%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 11:40 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD4RVY
ISINDE000HD4RVY9
Date issued 2024-04-17
Strike 500 $
Maturity 2025-01-15 (202 Days)
Parity 100 : 1
Emission price 0.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.85
Lowest since issue 0.4
Spread 0.01
Spread %2.22%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
488.6 USD
Average target price
564.1 USD
Spread / Average Target
+15.46%
Consensus